Changes in the gene activity of immune cells may help flag people who have multiple sclerosis or are likely to develop it, a ...

It's been one week since Wanda Lee-Ballou received University of Virginia (UVA) Health's first dose of Ocravus Zunovo – the ...

Diagnosed with multiple sclerosis at age 35, the FOX News senior meteorologist thought her life was over. Now, nearly two ...

Lady Sarra Hoy, a charity ambassador and mum, has announced that she was diagnosed with MS just before Sir Chris discovered ...

In a study of commonly used treatments for multiple sclerosis, both medical and behavioral interventions, and a combination of the two, resulted in significant improvements in fatigue. Researchers say ...

Oct. 17, 2024 — In a study of commonly used treatments for multiple sclerosis, both medical and behavioral interventions, and a combination of the two, resulted in significant improvements in ...

Sanofi has stopped a phase 2 trial of Denali Therapeutics-partnered oditras | Sanofi has stopped a phase 2 trial of the ...

A recent study showed that both cognitive behavioral therapy (CBT) and the mild stimulant modafinil (Provigil) reduced MS ...

Helius is opposing decisions on how much of the costs of its PoNS device for MS can be reimbursed under U.S. public health ...

What used to take hours, we can now do in less than 30 minutes”: FDA OKs new treatment for people suffering from multiple ...

Some cancers occurred more frequently in people with multiple sclerosis (MS) than in others, a retrospective study in France ...

The COMBO-MS trial, reported in The Lancet Neurology by Tiffany Braley and colleagues,1 is the first pragmatic, randomised, controlled trial that compares head-to-head the benefits and harms of a ...